A detailed history of Eagle Bay Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 33 shares of MRNA stock, worth $2,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 33 -0.0%
Holding current value
$2,169
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $1,253 - $1,645
-13 Reduced 28.26%
33 $3,000
Q4 2022

Jan 26, 2023

SELL
$118.38 - $210.04 $38,710 - $68,683
-327 Reduced 87.67%
46 $0
Q3 2022

Nov 22, 2022

BUY
$118.07 - $194.18 $10,980 - $18,058
93 Added 33.21%
373 $44,000
Q2 2022

Aug 19, 2022

BUY
$117.13 - $176.59 $32,796 - $49,445
280 New
280 $40 Million
Q1 2022

May 11, 2022

SELL
$126.46 - $235.05 $13,657 - $25,385
-108 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$225.82 - $368.51 $16,259 - $26,532
72 Added 200.0%
108 $27,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $7,988 - $17,440
36 New
36 $14,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.